TDM for Optimized Outcome in Patients With mRCC.
TDM for Optimized Outcome in Patients With mRCC.
Recruiting · NCT04659343 · Registry updated 2026-05-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TDM for Optimized Outcome in Patients With mRCC. | Chemically-Induced Disorders, Drug Toxicity, Drug-Related Side Effects and Adverse Reactions, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, kidney cancer, kidney disorder, neoplasm, urinary system disorder | Recruiting | Not stated | 2026-05-04 | NCT04659343 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Copenhagen University Hospital, Rigshospitalet | 330 |
| Herlev Hospital | 63 |
| Niels Fristrup | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Oncology, Aarhus University Hospital | Aarhus | Denmark | 1 |